GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Veradigm Inc (OTCPK:MDRX) » Definitions » Shares Outstanding (EOP)

Veradigm (Veradigm) Shares Outstanding (EOP) : 109 Mil (As of Sep. 2022)


View and export this data going back to 1999. Start your Free Trial

What is Veradigm Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Veradigm's shares outstanding for the quarter that ended in Sep. 2022 was 109 Mil.

Veradigm's quarterly shares outstanding declined from Jun. 2022 (111 Mil) to Sep. 2022 (109 Mil). It means Veradigm bought back shares from Jun. 2022 to Sep. 2022 .

Veradigm's annual shares outstanding declined from Dec. 2020 (140 Mil) to Dec. 2021 (116 Mil). It means Veradigm bought back shares from Dec. 2020 to Dec. 2021 .


Veradigm Shares Outstanding (EOP) Historical Data

The historical data trend for Veradigm's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veradigm Shares Outstanding (EOP) Chart

Veradigm Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 180.83 171.22 162.48 139.94 116.11

Veradigm Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 122.57 116.11 114.79 110.79 109.26

Competitive Comparison of Veradigm's Shares Outstanding (EOP)

For the Health Information Services subindustry, Veradigm's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Veradigm's Shares Outstanding (EOP) Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Veradigm's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Veradigm's Shares Outstanding (EOP) falls into.



Veradigm Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


Veradigm  (OTCPK:MDRX) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Veradigm Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of Veradigm's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


Veradigm (Veradigm) Business Description

Traded in Other Exchanges
N/A
Address
222 Merchandise Mart Plaza, Suite 2024, Chicago, IL, USA, 60654
Veradigm Inc is a healthcare technology company that drives value through its various combination of platforms, data, expertise, connectivity, and scale. It delivers a combination of point-of-care clinical and financial solutions. The Veradigm Network features a dynamic community of solutions and partners providing insights, technology, and data-driven solutions, all working together to transform healthcare insightfully.
Executives
Shih Yin Ho director 222 MERCHANDISE MART, SUITE 2024, CHICAGO IL 60654
Susan Rodriguez director C/O ARDELYX, INC., 34175 ARDENWOOD BLVD, SUITE 200, FREMONT CA 94555
Richard J. Poulton officer: CFO 3646 WESTFIELD LANE, GLENVIEW IL 60026
Tejal Vakharia officer: SVP Gerneral Counsel 222 MERCHANDISE MART PLZ, SUITE 2024, CHICAGO IL 60654
David B Stevens director 1 IMATION WAY, OAKDALE MN 55128
Leah Jones officer: Chief Financial Officer 222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654
Paul Black director 400 WOOD ROAD, BRAINTREE MA 02184
Elizabeth Ann Altman director 10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Thomas Langan officer: President and CCO 222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654
Lisa Hammond officer: SVP & Chief HR Officer 305 CHURCH AT NORTH HILLS STREET, RALEIGH NC 27609
Greg Garrison director 222 MERCHANDISE MART PLAZA, CHICAGO IL 60654
Lisa Khorey officer: Chief Client Delivery Officer 222 MERCHANDISE MART PLAZA, CHICAGO IL 60654
Michael Klayko director
Carol J Zierhoffer director 100 NORTH POINT CENTER EAST, SUITE 200, ALPHARETTA GA 30022
Brian Farley officer: SVP Gerneral Counsel & Corpora 222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654

Veradigm (Veradigm) Headlines

From GuruFocus